Company: OPGN
Filing Date: 2025-08-21
Form Type: 10-K
Source: 0001829126-25-006628
Chunk: 744

Company: OPGEN INC
Filing Date: 2025-08-21
Form: 10-K
Item: Item 3
Chunk 744
---
    (908,586
    )

    -

    Foreign currency transaction gains (losses)

    575

    (289,306
    )
  
    Change in fair value of derivative financial instruments

    -

    65,876

    Total other income (expense)

    11,844,725

    (1,919,875
    )
  
    Income (loss) before income taxes

    12,169,442

    (32,668,530
    )
  
    Provision for income taxes

    (176,662
    )

    -

    Net income (loss)
     
    $
    11,992,780

    $
    (32,668,530
    )

    Net income (loss) allocated to preferred stockholders - basic

    (636,742
    )

    -

    Net income (loss) available to common stockholders - basic
     
    $
    11,356,038

    $
    (32,668,530
    )

    Net income (loss)
     
    $
    11,992,780

    $
    (32,668,530
    )

    Net income (loss) allocated to preferred stockholders - diluted

    -

    -

    Net income (loss) available to common stockholders - diluted
     
    $
    11,992,780

    $
    (32,668,530
    )

    Earnings (loss) per share attributable to common stockholders

    Basic
     
    $
    2.44

    $
    (41.47
    )
  
    Diluted
     
    $
    2.30

    $
    (41.47
    )

    Weighted average shares outstanding

    Basic

    4,655,225

    787,832

    Diluted

    5,219,902

    787,832

    Net income (loss)
     
    $
    11,992,780

    $
    (32,668,530
    )
  
    Other comprehensive income (loss) - foreign currency translation

    -

    720,702

    Comprehensive income (loss)
     
    $
    11,992,780

    $
    (31,947,828
    )

See accompanying notes to consolidated financial statements.

F-6

OpGen, Inc.

Consolidated Statements of Stockholders’ Equity (Deficit